Provided By GlobeNewswire
Last update: Oct 2, 2024
AUDUBON, Pa., Oct. 02, 2024 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, announces the continued growth and expansion of its orthopedic trauma product portfolio.
80.28
-3.84 (-4.56%)
Find more stocks in the Stock Screener
Based on Fundamental Analysis it can be said that NYSE:GMED is a growth stock which is not overvalued.